Kay Ohtie on Nostr: Love how the DEA placing manufacturing limits on drug manufacturers for medications ...

Love how the DEA placing manufacturing limits on drug manufacturers for medications is leading to shortages of medications most people use because they seem to treat it like "well if we distribute even percentages for amphetamine salts, methylphenidate, and lisdexamfetamine, then clearly ADHD people will also evenly split across usage of them" like they're just filling generic water bottles, and not like, meeting actual demands/needs.

This is the DEA practicing medicine without a license, effectively, which is nearly as bad as when insurance companies do it.